HK Stock MarketDetailed Quotes

HOSPITAL CORP (03869)

Watchlist
  • 3.460
  • 0.0000.00%
Market Closed May 6 09:00 CST
478.15MMarket Cap3.17P/E (TTM)

HOSPITAL CORP (03869) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
Turnover
1.99%1.47B
3.27%743.04M
1.02%1.44B
0.23%719.5M
24.92%1.43B
32.71%717.83M
119.68%1.14B
161.00%540.92M
30.33%520.29M
14.71%207.25M
Operating income
1.99%1.47B
3.27%743.04M
1.02%1.44B
0.23%719.5M
24.92%1.43B
32.71%717.83M
119.68%1.14B
161.00%540.92M
30.33%520.29M
14.71%207.25M
Cost of sales
-3.17%-1.2B
-5.14%-595.99M
1.84%-1.17B
5.15%-566.88M
-19.79%-1.19B
-27.50%-597.68M
-224.14%-992.07M
-334.04%-468.76M
-49.38%-306.06M
-8.03%-108M
Operating expenses
-3.17%-1.2B
-5.14%-595.99M
1.84%-1.17B
5.15%-566.88M
-19.79%-1.19B
-27.50%-597.68M
-224.14%-992.07M
-334.04%-468.76M
-49.38%-306.06M
-8.03%-108M
Gross profit
-2.97%267.62M
-3.65%147.05M
15.23%275.82M
27.02%152.62M
58.64%239.36M
66.52%120.15M
-29.57%150.88M
-27.30%72.16M
10.24%214.23M
22.98%99.25M
Selling expenses
89.44%-17K
89.38%-17K
89.73%-161K
74.64%-160K
-355.81%-1.57M
-123.76%-631K
82.85%-344K
66.39%-282K
-50,050.00%-2.01M
---839K
Administrative expenses
-11.19%-121.15M
-25.66%-62.37M
15.69%-108.95M
-0.89%-49.64M
-35.81%-129.23M
-39.51%-49.2M
0.74%-95.16M
-67.48%-35.27M
-84.73%-95.87M
28.64%-21.06M
Impairment and provision
-185,938.10%-39.07M
----
-102.38%-21K
----
100.19%884K
----
20.11%-462.15M
15.76%-460.95M
15.34%-578.46M
18.57%-547.2M
-Impairment of intangible assets
----
----
----
----
----
----
16.61%-460.28M
15.19%-460.28M
17.40%-551.98M
18.78%-542.72M
-Other impairment is provision
-185,938.10%-39.07M
----
-102.38%-21K
----
147.35%884K
----
92.95%-1.87M
85.23%-662K
-75.61%-26.48M
-19.42%-4.48M
Special items of operating profit
-8.51%13.89M
-10.14%9.87M
-17.48%15.18M
491.54%10.98M
114.02%18.39M
105.94%1.86M
-585.35%-131.21M
-123.26%-31.23M
-80.83%27.04M
-258.31%-13.99M
Operating profit
-33.32%121.27M
-16.94%94.53M
42.26%181.86M
57.67%113.81M
123.76%127.84M
115.84%72.18M
-23.65%-537.99M
5.84%-455.57M
-8.81%-435.07M
20.93%-483.84M
Financing income
160.45%65.32M
296.58%106.72M
---108.05M
-142.15%-54.29M
----
1,491.23%128.79M
116.83%14.6M
118.99%8.09M
-63.45%6.73M
-82.50%3.7M
Financing cost
----
----
----
----
1,056.45%88.37M
----
55.50%-9.24M
68.21%-4.09M
61.84%-20.76M
-15.95%-12.86M
Earning before tax
152.81%186.59M
238.14%201.25M
-65.86%73.81M
-70.39%59.52M
140.59%216.2M
144.51%200.97M
-18.60%-532.63M
8.41%-451.56M
-3.05%-449.1M
18.09%-493M
Tax
-0.18%-47.56M
9.24%-32.63M
0.80%-47.48M
-55.92%-35.95M
-1,287.30%-47.86M
-261.57%-23.06M
-95.35%4.03M
-82.72%14.27M
487.68%86.71M
136.47%82.58M
After-tax profit from continuing operations
428.05%139.03M
615.46%168.62M
-84.36%26.33M
-86.75%23.57M
131.85%168.34M
140.69%177.92M
-45.86%-528.6M
-6.55%-437.29M
13.93%-362.4M
27.61%-410.42M
Earning after tax
428.05%139.03M
615.46%168.62M
-84.36%26.33M
-86.75%23.57M
131.85%168.34M
140.69%177.92M
-45.86%-528.6M
-6.55%-437.29M
13.93%-362.4M
27.61%-410.42M
Minority profit
-95.02%2.61M
-66.29%14.9M
41.82%52.42M
-14.47%44.22M
177.57%36.96M
--51.7M
41.67%-47.65M
----
-388.35%-81.69M
-119.44%-69.32M
Profit attributable to shareholders
622.89%136.42M
844.50%153.72M
-119.86%-26.09M
-116.36%-20.65M
127.32%131.38M
128.86%126.22M
-71.33%-480.95M
-28.20%-437.29M
30.58%-280.71M
36.29%-341.1M
Basic earnings per share
626.32%1
853.33%1.13
-119.87%-0.19
-116.48%-0.15
127.47%0.956
129.45%0.91
-71.34%-3.48
-25.10%-3.09
30.59%-2.031
36.18%-2.47
Diluted earnings per share
284.21%0.35
260.00%0.24
-189.20%-0.19
-650.00%-0.15
106.12%0.213
99.35%-0.02
-71.34%-3.48
-25.10%-3.09
30.59%-2.031
36.18%-2.47
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
KPMG
--
KPMG
--
KPMG
--
KPMG
--
PwC
--
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021
Turnover 1.99%1.47B3.27%743.04M1.02%1.44B0.23%719.5M24.92%1.43B32.71%717.83M119.68%1.14B161.00%540.92M30.33%520.29M14.71%207.25M
Operating income 1.99%1.47B3.27%743.04M1.02%1.44B0.23%719.5M24.92%1.43B32.71%717.83M119.68%1.14B161.00%540.92M30.33%520.29M14.71%207.25M
Cost of sales -3.17%-1.2B-5.14%-595.99M1.84%-1.17B5.15%-566.88M-19.79%-1.19B-27.50%-597.68M-224.14%-992.07M-334.04%-468.76M-49.38%-306.06M-8.03%-108M
Operating expenses -3.17%-1.2B-5.14%-595.99M1.84%-1.17B5.15%-566.88M-19.79%-1.19B-27.50%-597.68M-224.14%-992.07M-334.04%-468.76M-49.38%-306.06M-8.03%-108M
Gross profit -2.97%267.62M-3.65%147.05M15.23%275.82M27.02%152.62M58.64%239.36M66.52%120.15M-29.57%150.88M-27.30%72.16M10.24%214.23M22.98%99.25M
Selling expenses 89.44%-17K89.38%-17K89.73%-161K74.64%-160K-355.81%-1.57M-123.76%-631K82.85%-344K66.39%-282K-50,050.00%-2.01M---839K
Administrative expenses -11.19%-121.15M-25.66%-62.37M15.69%-108.95M-0.89%-49.64M-35.81%-129.23M-39.51%-49.2M0.74%-95.16M-67.48%-35.27M-84.73%-95.87M28.64%-21.06M
Impairment and provision -185,938.10%-39.07M-----102.38%-21K----100.19%884K----20.11%-462.15M15.76%-460.95M15.34%-578.46M18.57%-547.2M
-Impairment of intangible assets ------------------------16.61%-460.28M15.19%-460.28M17.40%-551.98M18.78%-542.72M
-Other impairment is provision -185,938.10%-39.07M-----102.38%-21K----147.35%884K----92.95%-1.87M85.23%-662K-75.61%-26.48M-19.42%-4.48M
Special items of operating profit -8.51%13.89M-10.14%9.87M-17.48%15.18M491.54%10.98M114.02%18.39M105.94%1.86M-585.35%-131.21M-123.26%-31.23M-80.83%27.04M-258.31%-13.99M
Operating profit -33.32%121.27M-16.94%94.53M42.26%181.86M57.67%113.81M123.76%127.84M115.84%72.18M-23.65%-537.99M5.84%-455.57M-8.81%-435.07M20.93%-483.84M
Financing income 160.45%65.32M296.58%106.72M---108.05M-142.15%-54.29M----1,491.23%128.79M116.83%14.6M118.99%8.09M-63.45%6.73M-82.50%3.7M
Financing cost ----------------1,056.45%88.37M----55.50%-9.24M68.21%-4.09M61.84%-20.76M-15.95%-12.86M
Earning before tax 152.81%186.59M238.14%201.25M-65.86%73.81M-70.39%59.52M140.59%216.2M144.51%200.97M-18.60%-532.63M8.41%-451.56M-3.05%-449.1M18.09%-493M
Tax -0.18%-47.56M9.24%-32.63M0.80%-47.48M-55.92%-35.95M-1,287.30%-47.86M-261.57%-23.06M-95.35%4.03M-82.72%14.27M487.68%86.71M136.47%82.58M
After-tax profit from continuing operations 428.05%139.03M615.46%168.62M-84.36%26.33M-86.75%23.57M131.85%168.34M140.69%177.92M-45.86%-528.6M-6.55%-437.29M13.93%-362.4M27.61%-410.42M
Earning after tax 428.05%139.03M615.46%168.62M-84.36%26.33M-86.75%23.57M131.85%168.34M140.69%177.92M-45.86%-528.6M-6.55%-437.29M13.93%-362.4M27.61%-410.42M
Minority profit -95.02%2.61M-66.29%14.9M41.82%52.42M-14.47%44.22M177.57%36.96M--51.7M41.67%-47.65M-----388.35%-81.69M-119.44%-69.32M
Profit attributable to shareholders 622.89%136.42M844.50%153.72M-119.86%-26.09M-116.36%-20.65M127.32%131.38M128.86%126.22M-71.33%-480.95M-28.20%-437.29M30.58%-280.71M36.29%-341.1M
Basic earnings per share 626.32%1853.33%1.13-119.87%-0.19-116.48%-0.15127.47%0.956129.45%0.91-71.34%-3.48-25.10%-3.0930.59%-2.03136.18%-2.47
Diluted earnings per share 284.21%0.35260.00%0.24-189.20%-0.19-650.00%-0.15106.12%0.21399.35%-0.02-71.34%-3.48-25.10%-3.0930.59%-2.03136.18%-2.47
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor KPMG--KPMG--KPMG--KPMG--PwC--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More